SCHEMBL19254474

SCHEMBL19254474

COc1cc(F)c([N+](=O)[O-])cc1Nc1nccc(Nc2cc(OC)c(OC)cc2C(C)=N)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.42
ALK Q9UM73 2/20 0.42
CDK9 P50750 2/20 0.40
CCNT1 O60563 1/20 0.40
AURKA O14965 6/20 0.39
AURKB Q96GD4 4/20 0.39
CDC7 O00311 1/20 0.39
LMNA P02545 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
MAPK8 P45983 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIM1 P11309 2/20 0.36
GSK3B P49841 2/20 0.36
CLK4 Q9HAZ1 2/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
PRKD3 O94806 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19254475 0.84 EGFR (0.49) EGFRALK
SCHEMBL29595342 0.81 AURKA (0.44) EGFRALKCDK9AURKAAURKB
SCHEMBL28729729 0.81 AURKA (0.44) EGFRALKCDK9AURKAAURKB
SCHEMBL28729877 0.80 EGFR (0.43) EGFRALKCDK9CCNT1AURKA
SCHEMBL30948608 0.79 EGFR (0.50) EGFRALKCDK9AURKAAURKB
SCHEMBL28663733 0.79 MAP4K1 (0.58) EGFRALKAURKAIGF1RMAP4K1
SCHEMBL30108148 0.78 ALK (0.42) EGFRALKCDK9CCNT1AURKA
SCHEMBL30948589 0.78 CCNT1 (0.42) EGFRALKCDK9CCNT1AURKB
SCHEMBL23761671 0.78 EGFR (0.54) EGFRALKCDK9CCNT1AURKA
SCHEMBL31630575 0.78 EGFR (0.54) EGFRALKCDK9CCNT1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3205650-A1 EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF Shanghai Hansoh Biomedical Co., Ltd. (CN) 2017-08-16 EP disclosed